Congratulations, you graduated this year! So, what happens next?

Author: Hamideh Emrani, 07/20/17

Passing by university campuses in the month of June, what you will notice is joyful, well dressed students, accompanied by family members, attending their graduation ceremonies. It is indeed a great feeling to have accomplished a university degree after a lot of dedication and hard work. I personally prefer the name commencement instead of graduation…Read more

Right Turn: Clinical trials – one solution to unapproved stem cell treatments

Author: Stacey Johnson, 07/14/17

I’ve been thinking about unapproved stem cell treatments a lot recently. First, I read this article that hailed the arrival of stem cell treatments in a small community in western Canada. There were many statements in the article that concerned me, but I only addressed a few major ones in my letter to the editor….Read more

Relay race to finish off inflammatory cells

Author: Holly Wobma, 07/12/17

I don’t have many distinct memories from childhood. Certainly not of global events. But given the sweltering weather, the recent Canada 150 celebration, and a cool new paper published in Cell Chemical Biology, my mind wandered back to the ’96 summer Olympics (Atlanta), when Donovan Bailey raced through the finish line with his arms in…Read more

Right Turn: How tea and humour are effective in knowledge translation – Part 2

Author: Stacey Johnson, 07/07/17

You’re back! Whether you stumbled onto this post or you sought it out following my introductory blog about Knowledge Translation (KT), I’m just glad you’re here. Now that you understand what KT is (hint: click on the link above if you need a definition) and why it’s essential that academics share their findings in a…Read more

Reimbursement – the final frontier

Author: Guest, 07/06/17

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging biotechnologies in Canada. Follow him on LinkedIN. Although I’m officially CCRM’s “regulatory guy,” I’ve been talking a…Read more

Right Turn: Beauty and brains – Disney updates inject STEM into classic tale

Author: Guest, 06/30/17

Malgosia Pakulska is the Communications and Development Officer at the Fields Institute for Research in Mathematical Sciences. She is also a science writer for Research2Reality, a blog designed to engage the public in Canadian research. Malgosia completed her PhD in Professor Molly Shoichet’s lab at the University of Toronto studying drug delivery systems for spinal cord regeneration…Read more

Immune to cancer, long-lived and really ugly

Author: Jovana Drinjakovic, 06/27/17

They could well be the ugliest animals on the planet, but naked mole rats don’t get cancer or suffer decrepitude from old age. No wonder scientists are working hard to unlock the secrets of these bizarre-looking creatures that could teach us how to stave off disease and repair brains. With large protruding teeth, squinting useless…Read more

Right Turn: Some knowledge sharing about Knowledge Translation – Part 1

Author: Stacey Johnson, 06/23/17

I’m delighted that, despite the title, you’ve decided to read this post! For some academics, knowledge translation is not the most exciting aspect of their job, but it is a requirement that must be fulfilled as part of their funding obligations. No offense to those who are professionals in the field and embrace the importance…Read more

What time zone is your heart tissue In?

Author: Holly Wobma, 06/19/17

Our lives our governed by our concept of time. Whether you are relatively spontaneous or a micromanager of your daily schedule, how we coordinate our work and interactions with other people comes down to the 24-hour clock we picture in our minds. Of course, this 24-hour clock is more than just a social construct. It…Read more

Right Turn: Primers on cell therapy regulation

Author: Stacey Johnson, 06/16/17

Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and development, manufacturing and clinical trials is media down the drain. Cell therapies present a range…Read more